EW
Edwards Lifesciences Corporation
NYSE · Healthcare · Medical - Devices · US
$89.90
+0.13%0
Insider buys (3m)
12
Insider sells (3m)
-$4.6M
Net value (3m)
+4.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 31, 2026 | Dahl Andrew M. · officer: SVP, Corporate Controller | Sale | 544 | $91 |
| Aug 28, 2026 | Bruls Annette · officer: CVP, EMEACLA | Sale | 2,644 | $90 |
| Aug 26, 2026 | Chopra Daveen · officer: CVP, TMTT, Surgical & IHFM | M-Exempt | 31,800 | $73 |
| Aug 26, 2026 | Chopra Daveen · officer: CVP, TMTT, Surgical & IHFM | Sale | 1,154 | $92 |
| Aug 26, 2026 | Markowitz Wayne · officer: CVP, JAPAC | Sale | 1,240 | $91 |
| Aug 26, 2026 | Chopra Daveen · officer: CVP, TMTT, Surgical & IHFM | Sale | 30,646 | $91 |
| Aug 11, 2026 | Lippis Daniel J. · officer: CVP, TAVR | Sale | 619 | $92 |
| Aug 11, 2026 | Lippis Daniel J. · officer: CVP, TAVR | M-Exempt | 619 | $73 |
| Jul 30, 2026 | Markowitz Wayne · officer: CVP, JAPAC | Sale | 146 | $86 |
| Jul 28, 2026 | Markowitz Wayne · officer: CVP, JAPAC | M-Exempt | 9,628 | $74 |
| Jul 28, 2026 | Markowitz Wayne · officer: CVP, JAPAC | Sale | 9,628 | $85 |
| Jul 27, 2026 | Zovighian Bernard J · director, officer: CEO | Sale | 2,921 | $84 |
| Jul 13, 2026 | Bruls Annette · officer: CVP, EMEACLA | F-InKind | 109 | $92 |
| Jul 10, 2026 | Lippis Daniel J. · officer: CVP, TAVR | M-Exempt | 619 | $73 |
| Jul 10, 2026 | Mistras Theodora · officer: CVP, Chief Financial Officer | A-Award | 12,325 | $0.00 |
| Jul 10, 2026 | Mistras Theodora · officer: CVP, Chief Financial Officer | A-Award | 61,800 | $91 |
| Jul 10, 2026 | Mistras Theodora · officer: CVP, Chief Financial Officer | A-Award | 87,595 | $0.00 |
| Jul 10, 2026 | Lippis Daniel J. · officer: CVP, TAVR | Sale | 619 | $92 |
| Jul 7, 2026 | Lippis Daniel J. · officer: CVP, TAVR | F-InKind | 377 | $95 |
| Jun 30, 2026 | Lippis Daniel J. · officer: CVP, TAVR | Sale | 619 | $91 |
| Jun 30, 2026 | Lippis Daniel J. · officer: CVP, TAVR | M-Exempt | 619 | $73 |
| Jun 17, 2026 | Zovighian Bernard J · director, officer: CEO | Sale | 523 | $88 |
| May 29, 2026 | Dahl Andrew M. · officer: SVP, Corporate Controller | Sale | 568 | $86 |
| May 27, 2026 | BOBO DONALD E JR · officer: CVP,Strategy/Corp Development | Sale | 23,145 | $86 |
| May 22, 2026 | Chopra Daveen · officer: CVP, TMTT & Surgical | Sale | 1,500 | $85 |
| May 18, 2026 | Lippis Daniel J. · officer: CVP, TAVR | Sale | 620 | $81 |
| May 18, 2026 | BOBO DONALD E JR · officer: CVP,Strategy/Corp Development | Sale | 8,000 | $82 |
| May 18, 2026 | BOBO DONALD E JR · officer: CVP,Strategy/Corp Development | Sale | 9,968 | $82 |
| May 18, 2026 | Lippis Daniel J. · officer: CVP, TAVR | M-Exempt | 620 | $73 |
| May 12, 2026 | BOBO DONALD E JR · officer: CVP,Strategy/Corp Development | M-Exempt | 13,457 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 280Increased 925Reduced 940Sold out 108
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 58,789,433 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 52,728,933 | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 37,727,792 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 37,615,952 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 26,411,402 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 26,407,018 | May 15, 2026 |
| STATE STREET CORP | Increased | 26,321,940 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 26,296,399 | May 15, 2026 |
| JPMORGAN CHASE & CO | Increased | 22,783,175 | Aug 12, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 22,011,101 | May 15, 2026 |
| JPMORGAN CHASE & CO | Reduced | 21,744,712 | May 13, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 16,827,967 | Aug 14, 2026 |
| BANK OF NEW YORK MELLON CORP | Reduced | 16,737,548 | May 5, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 15,437,251 | Aug 12, 2026 |
| FMR LLC | Reduced | 14,503,770 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 31, 2026